Analysis of safety data collected from veterinary effectiveness studies.
View Presentation *Michele Sharkey, FDA/CVM Keywords: clinical findings, safety concerns Important information about the safe use of veterinary drug products may be gleaned from the clinical pathology data obtained during the field study. Although these studies are limited in the number of subjects, often multiple clinical pathology samples offer insight into possible issues or safety concerns when using the drug under actual conditions of use. The presentation will be a veterinarian’s clinical perspective with a primary focus on companion animal drug studies, and some insight into production and food animal drug studies. Discussion will include the importance of outliers, trends, and determining the relationship between clinically and statistically significant findings.
|
Key Dates
-
April 30 - May 22, 2013
Invited Abstract Submission Open -
June 4, 2013
Online Registration Opens -
August 9 - August 23, 2013
Invited Abstract Editing -
August 23, 2013
Short Course materials due from Instructors -
August 26, 2013
Housing Deadline -
September 9, 2013
Cancellation Deadline and Registration Closes @ 11:59 pm EDT -
September 16 - September 18, 2013
Marriott Wardman Park, Washington, DC